Announcements Trials
Browse Landscape

Status

Completed 3Terminated 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 13Genitourinary 12Gastrointestinal 12Breast 11Head & Neck 6Tumor-Agnostic 5Other hematologic neoplasm 5Lymphoid 5Thoracic 4Plasma cell 3Other 3Gynecologic 3Other neoplasm 1Myeloid 1Dermatologic 1CNS 1

Conditions

Genetic Predisposition to Disease 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 78Magnetic Resonance Spectroscopy 69Specimen Handling 45Radiotherapy 42Bevacizumab 28Radiosurgery 27Cyclophosphamide 27pembrolizumab 20Radiation 20Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 14Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11Surgical Procedures, Operative 9trametinib 8dinutuximab 8abemaciclib 8Ipilimumab 8Fluorodeoxyglucose F18 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interviews as Topic × CNS × Clear all
NCT02530658 2026-04-29

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

St. Jude Children's Research Hospital

Recruiting
2,500 enrolled
CNS

Central Nervous System Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡